Personen
Dr. rer. nat. Manju Kumari

Arbeitsgruppenleiterin (Cardiac Immunometabolism)


06221 56-310561

Ärztlicher / Beruflicher Werdegang

seit 2021

Junior Group Leader, Department of Cardiology, Angiology and Pneumology, Universitätsklinikum Heidelberg, Heidelberg, Germany

2020 – 2021

Senior Postdoctoral Research Fellow, Universitätsklinikum-Hamburg Eppendorf, Hamburg, Germany

2017 – 2020

Alexander von Humboldt Postdoctoral Research Fellow, Universitätsklinikum-Hamburg Eppendorf, Hamburg, Germany

2012 – 2017

Postdoctoral Research Fellow, Division of Endocrinology, BIDMC, Harvard University, Boston, USA

2007 – 2012

Graduate student, University of Graz, Graz, Austria

2003 – 2007

Junior Scientist, Dr. Reddy’s Laboratory, Hyderabad, India

Wissenschaftlicher Werdegang

2007 – 2012

PhD in Biochemistry and Molecular Cell Biology, University of Graz, Austria

2001 – 2003

Master of Science in Biochemistry, University of Pune, India

1998 – 2001

Bachelor of Science in Chemistry, University of Pune, India

Auszeichnungen

2017

Alexander von Humboldt Postdoctoral Research Fellowship

2016

American Diabetes Association, Oral Speaker, New Orleans, USA

2015

Keystone Symposia Award, Oral Speaker, Copenhagen, Denmark

2011

Keystone Symposia Award, Conference Assistant, Killarney, Ireland

2007

University International Postgraduate Award at UNSW, Australia (gracefully denied)

2003

NET (LS) Qualified by CSIR-UGC-NET, India

Stipendien

2017

Alexander von Humboldt Postdoctoral Research Fellowship

2007

University International Postgraduate Award at UNSW, Australia (gracefully denied)

2001 – 2003

Dr. Reddy’s Laboratory Masters Fellowship

Mitgliedschaften

German Centre for Cardiovascular Research (DZHK)

European Atherosclerosis  Society (EAS)

American Heart Association (AHA)

American Diabetes Association (ADA)

Forschungsschwerpunkte

Activation of pro-inflammatory signaling pathways play a key role in the progression of skeletal and cardiovascular disorders. These pathways initiate cell-type specific transcriptional alterations and exert various metabolic effects via cellular cross-talk. We are interested in investigating the contribution of immuno-regulatory transcriptional pathways in the pathology of muscle disorders. Our focus is to increase the understanding on cellular and metabolic interactome involved in cellular remodeling by identifying novel therapeutic targets.